Photo of Professor Steve Rannard

Professor Steve Rannard BSc (Hons), D.Phil., FRSC

Professor Chemistry

Research

Research Interest 1

Please see the Rannard Group website http://rannardgroup.wix.com/rannardgroup for full details of our current research, archives of our publications and current vacancies.

The group researches novel polymer chemistry and organic nanoparticle production for many potential applications including nanomedicine. Within our nanomedicine programmes, we are highly focussed on infectious diseases including HIV, where our outputs are targeting clinically relevant translational technologies.

Research Grants

New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

July 2018 - June 2022

New Polymers from Multi-Vinyl Monomer Homopolymerisation

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC), UK RESEARCH AND INNOVATION (UKRI) (UK)

November 2017 - October 2021

Long acting NRTI therapies for HIV

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

July 2017 - June 2021

An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

April 2019 - April 2022

In vitro and in vivo assessment of nanoemulsion co-formulations of dolutegravir and rilpivirine.

BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)

June 2017 - December 2018

Sustained, injectable ocular drug delivery systems

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

October 2018 - September 2022

DTP Studentship - Industry Top-Up

ITACONIX LTD (UK)

October 2017 - September 2021

Evaluating biosubstrate triggered emulsions for step change product design and development

INNOVATE UK (UK)

April 2017 - April 2018

Croda Branched Polymers

CRODA (UK)

March 2018 - March 2019

Microneedle patches for antiretroviral delivery

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

August 2019 - July 2022

EPSRC Institutional Sponsorship 2016

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

July 2016 - March 2017

European Nanotechnology Characterisation Laboratory

EUROPEAN COMMISSION

May 2015 - December 2019

Nanoparticle Interventions for Colorectal Cancer

CANCER RESEARCH UK (CRUK) (UK)

October 2016 - September 2021

Antiretroviral therapy (ART) simplification

WITS REPRODUCTIVE HEALTH & HIV INSTITUTE (S AFRICA)

October 2015 - October 2020

Development of solid drug nanoparticle for treatment of mycobacterium tuberculosis

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

October 2013 - December 2013

Towards NanoMedicine Interventions for HIV/AIDS

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

May 2012 - November 2016

Integrated radiomaterials chemistry for simultaneous multi-component tracking of nanomedicines in biological matrices

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

September 2014 - March 2018

Pickering-stabilised Nanoemulsions as Novel Antiretroviral Drug Delivery Systems

BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)

October 2009 - September 2013

Royal Society Industry Fellowship - Transfer from Unilever

ROYAL SOCIETY (OST)

September 2007 - June 2009

Application of nanomedicine to childhood diseases.

ALDER HEY CHILDREN'S NHS FOUNDATION TRUST (UK)

October 2013 - September 2016

New Nanoscale Drug Delivery Systems and their Application to HIV/AIDS treatment

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

November 2011 - April 2016

Non-Attrition HAART nanoparticle therapies for HIV/AIDS Drug Delivery

ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC)

May 2009 - October 2012

Towards complete sustained release nanoformulations of NRTI based regimens

NATIONAL INSTITUTES OF HEALTH (NIH) (USA)

July 2014 - June 2019

Liverpool Imaging Partnership: Molecular physiology and drug response

MEDICAL RESEARCH COUNCIL (MRC)

February 2013 - February 2017